Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Medical oversight A key point regarding GLP-1 medications, including in a microdosing context, is that they are prescription drugs designed for specific medical conditions (like type 2 diabetes and obesity) and require professional guidance
Every step of the production process is strictly controlled
Deficiencies can occur with medical conditions such as atrophic gastritis (which causes thinning of the stomach lining), pernicious anaemia, Crohns disease, celiac disease, lupus, or other immune system disorders and certain medications
The trial aims to enroll 700 participants, and will run 78 weeks (estimated readout 1H 2025)
US$ 26.76
US$ 24.29
US$ 25.43
